CITADEL ADVISORS LLC 13D and 13G filings for Ventyx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | CITADEL ADVISORS LLC | 4,279,553 7.300% | 490,758 (+12.95%) | Filing |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | CITADEL ADVISORS LLC | 3,788,795 6.700% | -102,278 (-2.63%) | Filing |
| 2022-02-14 06:26 am Purchase | 2021-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | CITADEL ADVISORS LLC | 3,891,073 7.700% | 455,133 (+13.25%) | Filing |
| 2021-11-04 4:21 pm Purchase | 2021-10-25 | 13G | Ventyx Biosciences, Inc. VTYX | CITADEL ADVISORS LLC | 3,435,940 6.800% | 3,435,940 (New Position) | Filing |